Xtl Biopharmaceuticals (XTLB) Revenue (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) posted Revenue of $289,000 for the quarter ended Dec 31, 2024.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Revenue (2010 - 2024) Analysis & Trends
For the year ended Dec 31, 2024, Xtl Biopharmaceuticals' Revenue came in at $451,000.
- Annual Revenue shows a four-year compound annual growth rate of 153.0% (years ended Dec 2020 to Dec 2024).
- In prior years, Xtl Biopharmaceuticals' Revenue was $11,000 in the year ended Dec 31, 2020.
- The figure for the quarter ended Dec 31, 2024 stands as the highest quarterly Revenue since the quarter ended Jun 30, 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | -283,000.00 |
| Mar 31, 2024 | 660,000.00 |
| Dec 31, 2023 | -84,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -201,000.00 |
| Mar 31, 2023 | -668,000.00 |
| Dec 31, 2022 | -523,000.00 |
| Sep 30, 2022 | -617,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | 755,000.00 |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | -585,000.00 |
| Jun 30, 2021 | -847,000.00 |
| Mar 31, 2021 | 518,000.00 |
| Dec 31, 2020 | -819,000.00 |
| Sep 30, 2020 | -729,000.00 |
| Jun 30, 2020 | -888,000.00 |
| Mar 31, 2020 | 430,000.00 |
API Access
Xtl Biopharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();